Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Xerri, L' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 59 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dales, JP; Plumas, J; Palmerini, F; Devilard, E; Defrance, T; Lajmanovich, A; Pradel, V; Birg, F; Xerri, L
      Correlation between apoptosis macroarray gene expression profiling and histopathological lymph node lesions

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    2. Dales, JP; Palmerini, F; Devilard, E; Hassoun, J; Birg, F; Xerri, L
      Caspases: Conductors of the cell death machinery in lymphoma cells

      LEUKEMIA & LYMPHOMA
    3. Vey, N; Camerlo, J; Xerri, L; Petit, N; Dermeche, S; Maraninchi, D
      Simultaneous occurrence of Kaposi's Sarcoma and chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    4. Palmerini, F; Devilard, E; Jarry, A; Birg, F; Xerri, L
      Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma

      HUMAN PATHOLOGY
    5. Bouabdallah, R; Abena, P; Chetaille, B; Aurran-Schleinitz, T; Sainty, D; Dubus, P; Arnoulet, C; Coso, D; Xerri, L; Gastaut, JA
      True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms

      BRITISH JOURNAL OF HAEMATOLOGY
    6. Cerdan, C; Devilard, E; Xerri, L; Olive, D
      The C-class chemokine lymphotactin costimulates the apoptosis of human CD4+ T cells

      BLOOD
    7. Xerri, L; Dales, JP; Devilard, E; Hassoun, J; Birg, F
      "Apoptosis" macro-array analysis of gene expression profiling in lymph node lesions

      BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    8. Charton-Bain, MC; Brousset, P; Bouabdallah, R; Gaulard, P; Merlio, JP; Dubus, P; Rostaing, L; de Roux, C; Weiller, PJ; Hassoun, J; Xerri, L
      Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma

      HISTOPATHOLOGY
    9. Bouabdallah, R; Coso, D; Costello, R; Bardou, VJ; Blaise, D; Xerri, L; Sainty, D; Maraninchi, D; Gastaut, JA
      Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center

      BONE MARROW TRANSPLANTATION
    10. Charafe-Jauffret, E; Moutardier, V; Civatte, M; Charton-Bain, MC; Delpero, JR; Hassoun, J; Xerri, L
      An ulcerative tumor of the fundic mucose

      ANNALES DE PATHOLOGIE
    11. Xerri, L
      Recent advance in the classification of tumors using microarrays

      ANNALES DE PATHOLOGIE
    12. Charton-Bain, MC; Lelong, B; Bouabdallah, R; Dubus, P; Merlio, JP; Hassoun, J; Xerri, L
      Primary hepatic lymphoma of MALT-type

      ANNALES DE PATHOLOGIE
    13. Xerri, L; Palmerini, F; Devilard, E; Defrance, T; Bouabdallah, R; Hassoun, J; Birg, F
      Frequent nuclear localization of ICAD and cytoplasmic co-expression of caspase-8 and caspase-3 in human lymphomas

      JOURNAL OF PATHOLOGY
    14. Chambost, H; Van Baren, N; Brasseur, F; Godelaine, D; Xerri, L; Landi, SJ; Theate, I; Plumas, J; Spagnoli, GC; Michel, G; Coulie, PG; Olive, D
      Expression of gene MAGE-A4 in Reed-Sternberg cells

      BLOOD
    15. Bouabdallah, R; Stoppa, AM; Rossi, JF; Lepeu, G; Coso, D; Xerri, L; Ladaique, P; Chabannon, C; Blaise, D; Bardou, VJ; Alzieu, C; Gastaut, JA; Maraninchi, D
      Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients

      LEUKEMIA
    16. Xerri, L; Devilard, E; Bouabdallah, R; Hassoun, J; Chaperot, L; Birg, F; Plumas, J
      Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin's lymphomas

      LEUKEMIA
    17. Bouabdallah, R; de Roux, C; Xerri, L; Granel, B; Serratrice, J; Weiller, PJ
      Cytomegalovirus retinitis revealing a leukemic gamma/delta T-cell lymphoma

      HAEMATOLOGICA
    18. Charton-Bain, MC; Terris, B; Dauge, MCH; Marche, C; Walker, F; Bouchaud, O; Xerri, L; Potet, F
      Reduced number of Langerhans cells in oesophageal mucosa from AIDS patients

      HISTOPATHOLOGY
    19. Oddou, S; Devilard, E; Dales, JP; Hassoun, J; Birg, F; Xerri, L
      Analysis of human gene expression using high-density cDNA filters

      ANNALES DE PATHOLOGIE
    20. Xerri, L; Devilard, E; Bouabdallah, R; Stoppa, AM; Hassoun, J; Birg, F
      FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis

      BRITISH JOURNAL OF HAEMATOLOGY
    21. XERRI L; HASSOUN J; DEVILARD E; BIRNBAUM D; BIRG F
      BCL-X AND THE APOPTOTIC MACHINERY OF LYMPHOMA-CELLS

      Leukemia & lymphoma
    22. BOUABDALLAH R; XERRI L; BARDOU VJ; STOPPA AM; BLAISE D; SAINTY D; MARANINCHI D; GASTAUT JA
      ROLE OF INDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULT LYMPHOBLASTIC LYMPHOMA - A REPORT ON 62 PATIENTS FROM A SINGLE-CENTER

      Annals of oncology
    23. QUILICHINI R; POUTSLAJUS P; BRECQUEVILLE JM; XERRI L; ZANLUCCA S; BAUME D
      RUPTURE OF THE SPLEEN REVEALING WALDENSTR OMS-DISEASE

      La Presse medicale
    24. PENAULTLLORCA F; BOUABDALLAH R; DEVILARD E; CHARTONBAIN MC; HASSOUN J; BIRG F; XERRI L
      ANALYSIS OF BAX EXPRESSION IN HUMAN TISSUES USING THE ANTI-BAX, 4F11 MONOCLONAL-ANTIBODY ON PARAFFIN SECTIONS

      Pathology research and practice
    25. Montero-Julian, FA; Dauny, I; Flavetta, S; Ronsin, C; Andre, F; Xerri, L; Wang, MH; Marvaldi, J; Breathnach, R; Brailly, H
      Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor

      HYBRIDOMA
    26. XERRI L; BROUSSE N
      GUIDELINES FOR DIAGNOSIS IN HEMATOPATHOLOGY - FOR A RATIONALIZATION OF HISTOLOGICAL, PHENOTYPIC AND GENOTYPIC DIAGNOSIS

      Annales de pathologie
    27. XERRI L; BOUABDALLAH R; DEVILARD E; HASSOUN J; STOPPA AM; BIRG F
      SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN B-CELL NON-HODGKINS-LYMPHOMAS AND IS MODERATELY INCREASED BY CD40 LIGATION

      British Journal of Cancer
    28. GISSELBRECHT C; GAULARD P; LEPAGE E; COIFFIER B; BRIERE J; HAIOUN C; CAZALSHATEM D; BOSLY A; XERRI L; TILLY H; BERGER F; BOUHABDALLAH R; DIEBOLD J
      PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS

      Blood
    29. XERRI L; DEVILARD E; HASSOUN J; HADDAD P; BIRG F
      MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS FREQUENTLY EXPRESS FAS LIGAND BUT DISPLAY A DIFFERENT SENSITIVITY TO FAS-MEDIATED APOPTOSIS

      Leukemia
    30. STOPPA AM; BOUABDALLAH R; CHABANNON C; NOVAKOVITCH G; VEY N; CAMERLO J; BLAISE D; XERRI L; RESBEUT M; DISTEFANO D; BARDOU VJ; GASTAUT JA; MARANINCHI D
      INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED BLOOD STEM-CELL SUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    31. CHARAFE E; PENAULTLLORCA F; MATHOULINPORTIER MP; BLADOU F; DELPERO JR; PRIMEGUITTON C; VIEILLEFOND A; XERRI L; HASSOUN J
      CLEAR-CELL SARCOMA OF THE KIDNEY - A RELA PSE AFTER 10 YEARS WITHOUT RECURRENCE

      Annales de pathologie
    32. XERRI L; DEVILARD E; AYELLO C; BROUSSET P; REED JC; EMILE JF; HASSOUN J; PARMENTIER S; BIRG F
      CYSTEINE PROTEASE CPP32, BUT NOT ICH1-L, IS EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS

      Human pathology
    33. XERRI L; DEVILARD E; HASSOUN J; OLIVE D; BIRG F
      IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS

      Journal of pathology
    34. XERRI L; DEVILARD E; HASSOUN J; BOUABDALLAH R; STOPPA AM; OLIVE D; BIRG F
      IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS

      Blood
    35. XERRI L; DEVILARD E; HASSOUN J; BOUABDALLAH R; BIRG F
      SENSITIVITY TO FAS-MEDIATED APOPTOSIS IS NULL OR WEAK IN NEOPLASTIC-CELLS FROM MOST SUBTYPES OF B-CELL NON-HODGKINS-LYMPHOMAS AND IS ONLY MODERATELY INCREASED BY CD40 LIGATION

      Blood
    36. MOREL P; XERRI L; COJEAN I; GAULARD P; TILLY H; BESUSCHIO S; CASASNOVAS O; DIEBOLD J
      PROGNOSTIC VALUE OF SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - A GELA STUDY ON 1487 PATIENTS

      Blood
    37. BOUABDALLAH R; STOPPA AM; COSO D; CHABANNON C; XERRI L; GASTAUT JA; MARANINCHI D
      INTENSIVE SEQUENTIAL CHEMOTHERAPY (ISC) WITH REPEATED BLOOD STEM-CELLSUPPORT FOR UNTREATED POOR-PROGNOSIS NON-HODGKINS-LYMPHOMAS (NHLS)

      Blood
    38. XERRI L; DEVILARD E; HASSOUN J; MAWAS C; BIRG F
      FAS LIGAND IS NOT ONLY EXPRESSED IN IMMUNE PRIVILEGED HUMAN ORGANS BUT IS ALSO COEXPRESSED WITH FAS IN VARIOUS EPITHELIAL TISSUES

      Journal of clinical pathology-Molecular pathology
    39. XERRI L; BATTYANI Z; GROB JJ; PARC P; HASSOUN J; BONERANDI JJ; BIRNBAUM D
      EXPRESSION OF FGF1 AND FGFR1 IN HUMAN-MELANOMA TISSUES

      Melanoma research
    40. COSTELLO RT; XERRI L; BOUABDALLAH R; GASTAUT JA; SAINTY D
      LEUKOPENIA, THROMBOCYTOPENIA, AND ACUTE AUTOIMMUNE HEMOLYTIC-ANEMIA ASSOCIATED WITH AN UNUSUAL (TYPE-2 4) HODGKINS-DISEASE - CASE-REPORT/

      American journal of hematology
    41. ATLANGEPNER C; BONGRAND P; FARNARIER C; XERRI L; CHOUX R; GAUTHIER JF; BRUE T; VAGUE P; GROB JJ; VIALETTES B
      INSULIN-INDUCED LIPOATROPHY IN TYPE-I DIABETES - A POSSIBLE TUMOR NECROSIS FACTOR-ALPHA-MEDIATED DEDIFFERENTIATION OF ADIPOCYTES

      Diabetes care
    42. XERRI L; PARC P; HASSOUN J; BIRNBAUM D
      MOLECULAR ANALYSIS OF THE NPM-ALK REARRANGEMENT IN HODGKINS-DISEASE

      Journal of pathology
    43. GAVIRAGHI G; PERBONI A; TAMBURINI B; XERRI L; SALVATORI A; SPADONI G; TARZIA G
      SYNTHESIS AND ANTIMICROBIAL EVALUATION OF ETA-CARBAMOYLMETHYL-PENAM-1,1-DIOXIDE-3-CARBOXYLIC ACID

      Il Farmaco
    44. XERRI L; PARC P; BROUSSET P; SCHLAIFER D; HASSOUN J; REED JC; KRAJEWSKI S; BIRNBAUM D
      PREDOMINANT EXPRESSION OF THE LONG ISOFORM OF BCL-X (BCL-XL) IN HUMANLYMPHOMAS

      British Journal of Haematology
    45. GISSELBRECHT C; GAULARD P; LEPAGE E; COIFFIER B; BRIERE FJ; HAIOUN C; CAZALS D; BOSLY A; XERRI L; TILLY H; BERGER F; BOUHABDALLAH R; DIEBOLD J
      PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS

      Blood
    46. DUSSOL B; BERNARD O; XERRI L; STOPPA AM; BRUNET P; MARANINCHI D; BERLAND Y
      EPSTEIN-BARR-VIRUS ASSOCIATED LYMPHOPROLI FERATION AFTER RENAL-TRANSPLANTATION - CONTRIBUTION OF GENOTYPIC ANALYSIS

      La Presse medicale
    47. XERRI L; CARBUCCIA N; PARC P; HASSOUN J; BIRG F
      FREQUENT EXPRESSION OF FAS APO-1 IN HODGKINS-DISEASE AND ANAPLASTIC LARGE-CELL LYMPHOMAS/

      Histopathology
    48. XERRI L; PARC P; BOUABDALLAH R; CAMERLO J; HASSOUN J
      PCR-MISMATCH ANALYSIS OF P53 GENE MUTATION IN HODGKINS-DISEASE

      Journal of pathology
    49. XERRI L; BATTYANI Z; BONERANDI JJ; HASSOUN J; GROB JJ
      NM-23 EXPRESSION AS A PROGNOSTIC MARKER IN METASTATIC MELANOMA

      Journal of investigative dermatology
    50. BATTAYANI Z; GROB JJ; XERRI L; NOE C; ZAROUR H; HOUVAENEGHEL G; DELPERO JR; BIRMBAUM D; HASSOUN J; BONERANDI JJ
      POLYMERASE CHAIN-REACTION DETECTION OF CIRCULATING MELANOCYTES AS A PROGNOSTIC MARKER IN PATIENTS WITH MELANOMA

      Archives of dermatology
    51. XERRI L; CARBUCCIA N; PARC P; BIRG F
      SEARCH FOR REARRANGEMENTS AND OR ALLELIC LOSS OF THE FAS/APO-1 GENE IN 101 HUMAN LYMPHOMAS/

      American journal of clinical pathology
    52. XERRI L; BIRG F; HASSOUN J
      ONCOGENES AND LYMPHOMAS

      Annales de pathologie
    53. DIMODUGNO E; ERBETTI I; FERRARI L; GALASSI G; HAMMOND SM; XERRI L
      IN-VITRO ACTIVITY OF THE TRIBACTAM GV104326 AGAINST GRAM-POSITIVE, GRAM-NEGATIVE, AND ANAEROBIC-BACTERIA

      Antimicrobial agents and chemotherapy
    54. XERRI L; BOUABDALLAH R; CAMERLO J; HASSOUN J
      EXPRESSION OF THE P53 GENE IN HODGKINS-DISEASE - DISSOCIATION BETWEENIMMUNOHISTOCHEMISTRY AND CLINICOPATHOLOGICAL DATA

      Human pathology
    55. GROB JJ; BATTYANI Z; XERRI L; HASSOUN J; BONERANDI JJ
      FIBROBLAST GROWTH-FACTORS EXPRESSION IN MELANOMA

      Journal of investigative dermatology
    56. XERRI L; GROB JJ; BATTYANI Z; GOUVERNET J; HASSOUN J; BONERANDI JJ
      NM23 EXPRESSION IN METASTASIS OF MALIGNANT-MELANOMA IS A PREDICTIVE PROGNOSTIC PARAMETER CORRELATED WITH SURVIVAL

      British Journal of Cancer
    57. XERRI L; MATHOULIN MP; BIRG F; BOUABDALLAH R; STOPPA AM; HASSOUN J
      HETEROGENEITY OF REARRANGED T-CELL RECEPTOR V-ALPHA AND V-BETA TRANSCRIPTS IN TUMOR-INFILTRATING LYMPHOCYTES FROM HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA

      American journal of clinical pathology
    58. BATTYANI Z; XERRI L; HASSOUN J; BONERANDI JJ; GROB JJ
      TYROSINASE GENE-EXPRESSION IN HUMAN TISSUES

      Pigment cell research
    59. MATHOULIN MP; XERRI L; JACQUEMIER J; ADELAIDE J; PARC P; HASSOUN J
      UNRESTRICTED T-CELL RECEPTOR V-REGION GENE REPERTOIRE IN TUMOR-INFILTRATING LYMPHOCYTES FROM HUMAN BREAST CARCINOMAS

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 02:33:18